Monitoring the Session

SB 493

pharmacists can tell you cash is cheaper

Became law, effective Sep 1, 2025

Verdict: No flags

No flagsInitial review
Sen. Lois KolkhorstRSenate 18

Initial review · graded Oct 22, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade

Caption

relating to protection of certain disclosures and communications by pharmacists and pharmacies regarding prescription drug benefits.

Caption from analyzed text · version F.

Summary

Pharmacy benefit managers can’t stop them.

The bill bars pharmacy benefit managers from stopping pharmacists or pharmacies from telling a patient when paying cash for a prescription would cost less than paying through their insurance benefit. It also voids any pharmacy benefit manager network contract term that blocks pharmacists from that disclosure or from talking with plan sponsors about drug benefits, network access, partnerships or claim payments. Starting September 1, 2025, pharmacists can speak freely on these points under any contract signed, amended or renewed after that date.

Receipt

The receipt

89R-SB493 · 2024-11-22

SOLD BY

+ 4 coauthors

ITEM

relating to protection of certain disclosures and communications by pharmacists and pharmacies regarding prescription drug benefits.

WHAT IT DOES

Pharmacy benefit managers can’t stop them.

The bill bars pharmacy benefit managers from stopping pharmacists or pharmacies from telling a patient when paying cash for a prescription would cost less than paying through their insurance benefit. It also voids any pharmacy benefit manager network contract term that blocks pharmacists from that disclosure or from talking with plan sponsors about drug benefits, network access, partnerships or claim payments. Starting September 1, 2025, pharmacists can speak freely on these points under any contract signed, amended or renewed after that date.

CHARGES

[ ] NONE FOUND

TOTAL

No significant fiscal implication to the State is anticipated.

LBB estimate · fiscal note version H · source

Sources

Fiscal note · version H · May 11, 2025

No first-year general revenue figure available here.

LBB published estimates · flow over the stated periods.

Source snapshot 2026-10-19, Central time.

HISTORY

  1. Received by the Secretary of the Senate
  2. Filed
  3. Read first time
  4. Referred to Health & Human Services
  5. Scheduled for public hearing on . . .
  6. Considered in public hearing
  7. Testimony taken in committee
  8. Left pending in committee
  9. Considered in public hearing
  10. Vote taken in committee
  11. Reported favorably as substituted
  12. Recommended for local & uncontested calendar
  13. Committee report printed and distributed
  14. Co-author authorized
  15. Co-author authorized
  16. Co-author authorized
  17. Placed on local & uncontested calendar
  18. Laid before the Senate
  19. Read 2nd time & passed to engrossment
  20. Vote recorded in Journal
  21. Three day rule suspended
  22. Record vote
  23. Read 3rd time
  24. Passed
  25. Record vote
  26. Reported engrossed
  27. Received from the Senate
  28. Read first time
  29. Referred to Insurance
  30. Scheduled for public hearing on . . .
  31. Considered in public hearing
  32. Testimony taken/registration(s) recorded in committee
  33. Left pending in committee
  34. Considered in formal meeting
  35. Committee substitute considered in committee
  36. Reported favorably as substituted
  37. Comte report filed with Committee Coordinator
  38. Committee report distributed
  39. Committee report sent to Calendars
  40. Considered in Calendars
  41. Placed on General State Calendar
  42. Read 2nd time
  43. Passed to 3rd reading
  44. Record vote RV#2971
  45. Statement(s) of vote recorded in Journal
  46. Read 3rd time
  47. Passed
  48. Record vote RV#3042
  49. House passage as amended reported
  50. House amendment(s) laid before the Senate
  51. Read
  52. Senate concurs in House amendment(s)
  53. Record vote
  54. Senate concurs in House amendment(s)-reported
  55. Reported enrolled
  56. Signed in the Senate
  57. Signed in the House
  58. Sent to the Governor
  59. Signed by the Governor
  60. Effective on 9/1/25
FILED UNDER

No verified beat found.

SIGNED FOR BY

House · 147 yea · 0 nay

Senate · 30 yea · 0 nay

Sources

House: Final passage · May 20, 2025. Journal. Published stock for this vote. Snapshot 2026-10-19, Central time.

Senate: Final passage · Apr 10, 2025. Journal. Published stock for this vote. Snapshot 2026-10-19, Central time.

All floor motions and other positions below.

No flags

THANK YOU FOR CHECKING THE RECEIPT

CAMPAIGN PAID FOR BY

CAMPAIGN PAID FOR BY

Donors

Not tied to this bill.

Sources

The author's campaign account only. Own money and internal transfers are separate on the member page.

Derived itemized flow · Jul 11, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Texans for Lawsuit Reform PAC$60,000.00

Texans for Lawsuit Reform PAC

$60,000.00

Cash
$60,000.00
Paid by others
$0.00
Total
$60,000.00

Also funds 124 other sitting lawmakers.

Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Nov 19, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101007416, 101012417, 101070754.

Border Health PAC$35,000.00

Border Health PAC

$35,000.00

Cash
$35,000.00
Paid by others
$0.00
Total
$35,000.00

Also funds 17 other sitting lawmakers.

Derived recipient stock · Oct 28, 2024 to Aug 26, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · on Dec 6, 2024. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101012417.

SRR Ranches, LLC$30,000.00

SRR Ranches, LLC

$30,000.00

Cash
$30,000.00
Paid by others
$0.00
Total
$30,000.00

Also funds 3 other sitting lawmakers.

Derived recipient stock · Oct 23, 2024 to Oct 8, 2026. State data as of Nov 4, 2026.

Name match, not a verified identity: normalized filed name and state.

Sources

Derived itemized flow · Oct 23, 2024 to Oct 1, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101012417, 101070754.

Money

Missing data does not establish zero giving. Display amounts are rounded.

×

Texans for Lawsuit Reform PAC

$60,000.00

Cash
$60,000.00
Paid by others
$0.00
Total
$60,000.00

Also funds 124 other sitting lawmakers.

Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Nov 19, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101007416, 101012417, 101070754.

×

Border Health PAC

$35,000.00

Cash
$35,000.00
Paid by others
$0.00
Total
$35,000.00

Also funds 17 other sitting lawmakers.

Derived recipient stock · Oct 28, 2024 to Aug 26, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · on Dec 6, 2024. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101012417.

×

SRR Ranches, LLC

$30,000.00

Cash
$30,000.00
Paid by others
$0.00
Total
$30,000.00

Also funds 3 other sitting lawmakers.

Derived recipient stock · Oct 23, 2024 to Oct 8, 2026. State data as of Nov 4, 2026.

Name match, not a verified identity: normalized filed name and state.

Sources

Derived itemized flow · Oct 23, 2024 to Oct 1, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101012417, 101070754.

Votes6

Senate May 22, 2025

Yea
31
Nay
0
Present, not voting
Not printed
Absent
Not printed
Excused
Not printed
Names

Senate journal

Names were not printed. No individual positions are inferred.

Sources

Senator Kolkhorst moved to concur in the House amendment to SB 493. The motion prevailed by the following vote: Yeas 31, Nays 0.

Published stock of positions for this vote, except where marked derived.

  • Yea: 31 (published)
  • Nay: 0 (published)
  • Present, not voting: Not printed
  • Absent: Not printed
  • Excused: Not printed

Senate journal. Source snapshot 2026-10-19, Central time.

House May 20, 2025

Yea
147
Nay
0
Present, not voting
2
Absent
0
Excused
1
Names

Named positions matched to lawmakers. See the journal for unmatched names.

House journal

Sources

Record 3042

SB 493 was passed by (Record 3042): 147 Yeas, 0 Nays, 2 Present, not voting.

Published stock of positions for this vote, except where marked derived.

  • Yea: 147 (published)
  • Nay: 0 (published)
  • Present, not voting: 2 (published)
  • Absent: 0 (derived from named list)
  • Excused: 1 (derived from named list)

House journal. Source snapshot 2026-10-19, Central time.

House May 19, 2025

Yea
141
Nay
0
Present, not voting
2
Absent
3
Excused
4
Names

Named positions matched to lawmakers. See the journal for unmatched names.

House journal

Sources

Record 2971

CSSB 493 was passed to third reading by (Record 2971): 141 Yeas, 0 Nays, 2 Present, not voting.

Published stock of positions for this vote, except where marked derived.

  • Yea: 141 (published)
  • Nay: 0 (published)
  • Present, not voting: 2 (published)
  • Absent: 3 (derived from named list)
  • Excused: 4 (derived from named list)

House journal. Source snapshot 2026-10-19, Central time.

Senate Apr 10, 2025

Final passage

Yea
30
Nay
0
Present, not voting
Not printed
Absent
Not printed
Excused
Not printed
Names

Senate journal

Names were not printed. No individual positions are inferred.

The journal row lists three votes in order: passage to engrossment, suspension of the three-day rule, and final passage. This entry records final passage. Repeated tallies belong to separate votes.

Sources

CSSB 493 (Kolkhorst) Relating to certain protected disclosures or communications by pharmacists and pharmacies regarding prescription drug benefits. (viva voce vote) (30-0) (30-0)

Published stock of positions for this vote, except where marked derived.

  • Yea: 30 (published)
  • Nay: 0 (published)
  • Present, not voting: Not printed
  • Absent: Not printed
  • Excused: Not printed

Senate journal. Source snapshot 2026-10-19, Central time.

Senate Apr 10, 2025

Suspension of the three-day rule

Yea
30
Nay
0
Present, not voting
Not printed
Absent
Not printed
Excused
Not printed
Names

Senate journal

Names were not printed. No individual positions are inferred.

The journal row lists three votes in order: passage to engrossment, suspension of the three-day rule, and final passage. This entry records suspension of the three-day rule. Repeated tallies belong to separate votes.

Sources

CSSB 493 (Kolkhorst) Relating to certain protected disclosures or communications by pharmacists and pharmacies regarding prescription drug benefits. (viva voce vote) (30-0) (30-0)

Published stock of positions for this vote, except where marked derived.

  • Yea: 30 (published)
  • Nay: 0 (published)
  • Present, not voting: Not printed
  • Absent: Not printed
  • Excused: Not printed

Senate journal. Source snapshot 2026-10-19, Central time.

Senate Apr 10, 2025

Passage to engrossment

Yea
Not printed
Nay
Not printed
Present, not voting
Not printed
Absent
Not printed
Excused
Not printed
Names

Senate journal

Names were not printed. No individual positions are inferred.

The journal row lists three votes in order: passage to engrossment, suspension of the three-day rule, and final passage. This entry records passage to engrossment. Repeated tallies belong to separate votes.

Voice vote. No numeric tally or individual yeas are inferred.

Sources

CSSB 493 (Kolkhorst) Relating to certain protected disclosures or communications by pharmacists and pharmacies regarding prescription drug benefits. (viva voce vote) (30-0) (30-0)

Published stock of positions for this vote, except where marked derived.

  • Yea: Not printed
  • Nay: Not printed
  • Present, not voting: Not printed
  • Absent: Not printed
  • Excused: Not printed

Senate journal. Source snapshot 2026-10-19, Central time.

Witnesses45
For
42
Against
1
On
2
Names

For

  • AARP Texas2 registrations
  • Americans for Prosperity, Texas2 registrations
  • Make Texans Healthy Again1 registration
  • Methodist Healthcare Ministries2 registrations
  • National Association of Benefits & Insurance Professionals, Texas Chapter1 registration
  • National Association of Benefits and Insurance Professionals1 registration
  • National Association of Chain Drug Stores2 registrations
  • Self5 registrations
  • Self; Americans for Prosperity1 registration
  • Self; Coalition of Texans with Disabilities1 registration
  • Self; Texas Association of Benefit Administrators1 registration
  • Self; Texas Eagle Forum1 registration
  • Self; Texas Federation of Drug Stores, National Association of Chain Drug Stores, and Walgreens1 registration
  • Self; Texas Pharmacy Association1 registration
  • Self; Texas Right To Know1 registration
  • Self; TFDS, TPA, NACDS1 registration
  • Self; TFDS; Brookshire Brothers Pharmacy1 registration
  • Self; The LIBRE Initiative1 registration
  • Texas 20362 registrations
  • Texas Association of Business1 registration
  • Texas association of community health centers1 registration
  • Texas Coalition for Patients1 registration
  • Texas Employers for Affordable Healthcare1 registration
  • Texas Federation of Drug Stores1 registration
  • Texas Healthcare and Bioscience Institute1 registration
  • Texas Medical Association2 registrations
  • Texas Pharmacy Association1 registration
  • Texas Pharmacy Business Council1 registration
  • Texas Watch1 registration
  • Texas Women's Healthcare Coalition2 registrations
  • United Supermarkets1 registration

Against

  • Self1 registration

On

  • TDI1 registration
  • Texas Department of Insurance1 registration
Sources

45 parsed registrations across the loaded witness lists.

Derived stock of witness registrations. Repeated appearances count separately. Organizations and self-representation appear as printed.

House witness list. Source snapshot 2026-10-20, Central time.

Senate witness list. Source snapshot 2026-10-20, Central time.

Fiscal

No significant fiscal implication to the State is anticipated.

LBB estimate · fiscal note version H · source

Sources

Fiscal note · version H · May 11, 2025

No first-year general revenue figure available here.

LBB published estimates · flow over the stated periods.

Source snapshot 2026-10-19, Central time.

How this was graded

Analysis of text version F by claude-opus-5-5, Oct 22, 2026, against the published rubric.

Sources

Texas Senate · Filed Nov 22, 2024

06/20/2025 E Effective on 9/1/25

Texas Legislature Online · Introduced · Senate Committee Report · Engrossed · House Committee Report · Enrolled

Data snapshot Oct 26, 2026 at 4:20 AM CDT. Grades, charges, quotes and corrections follow the published record.

Coauthors
Sponsors

House committee · Insurance · Committee vote 7 aye, 0 nay, 2 absent · Out of committee

Senate committee · Health & Human Services · Committee vote 7 aye, 0 nay, 2 absent · Out of committee

Subjects

Insurance--Health & Accident

Occupational Regulation--Health Occupations

MEDICINE & PRESCRIPTION DRUGS

PHARMACIES & PHARMACISTS

PHARMACY BENEFIT MANAGERS

Text

The text as introduced · 640 words

89R5182 DNC-D

By: Kolkhorst
S.B. No. 493

A BILL TO BE ENTITLED

AN ACT

relating to certain protected disclosures by pharmacists and

pharmacies regarding amounts charged for prescription drugs.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Chapter 1369, Insurance Code, is amended by

adding Subchapter R to read as follows:

SUBCHAPTER R. PROTECTED PRACTICES REGARDING PRESCRIPTION DRUG

CHARGES

Sec. 1369.801. DEFINITIONS. In this subchapter:

(1) "Enrollee" means an individual who is covered

under a health benefit plan, including a covered dependent.

(2) "Prescription drug" has the meaning assigned by

Section 551.003, Occupations Code.

Sec. 1369.802. APPLICABILITY OF SUBCHAPTER. (a) This

subchapter applies only to a health benefit plan that provides

benefits for medical or surgical expenses incurred as a result of a

health condition, accident, or sickness, including an individual,

group, blanket, or franchise insurance policy or insurance

agreement, a group hospital service contract, or an individual or

group evidence of coverage or similar coverage document that is

issued by:

(1) an insurance company;

(2) a group hospital service corporation operating

under Chapter 842;

(3) a health maintenance organization operating under

Chapter 843;

(4) an approved nonprofit health corporation that

holds a certificate of authority under Chapter 844;

(5) a multiple employer welfare arrangement that holds

a certificate of authority under Chapter 846;

(6) a stipulated premium company operating under

Chapter 884;

(7) a fraternal benefit society operating under

Chapter 885;

(8) a Lloyd's plan operating under Chapter 941; or

(9) an exchange operating under Chapter 942.

(b) Notwithstanding any other law, this subchapter applies

to:

(1) a small employer health benefit plan subject to

Chapter 1501, including coverage provided through a health group

cooperative under Subchapter B of that chapter;

(2) a standard health benefit plan issued under

Chapter 1507;

(3) a basic coverage plan under Chapter 1551;

(4) a basic plan under Chapter 1575;

(5) a primary care coverage plan under Chapter 1579;

(6) a plan providing basic coverage under Chapter

1601;

(7) health benefits provided by or through a church

benefits board under Subchapter I, Chapter 22, Business

Organizations Code;

(8) group health coverage made available by a school

district in accordance with Section 22.004, Education Code;

(9) the state Medicaid program, including the Medicaid

managed care program operated under Chapter 540, Government Code;

(10) the child health plan program under Chapter 62,

Health and Safety Code;

(11) a regional or local health care program operated

under Section 75.104, Health and Safety Code;

(12) a self-funded health benefit plan sponsored by a

professional employer organization under Chapter 91, Labor Code;

(13) county employee group health benefits provided

under Chapter 157, Local Government Code; and

(14) health and accident coverage provided by a risk

pool created under Chapter 172, Local Government Code.

(c) This subchapter applies to coverage under a group health

benefit plan provided to a resident of this state regardless of

whether the group policy, agreement, or contract is delivered,

issued for delivery, or renewed in this state.

Sec. 1369.803. PROTECTED DISCLOSURE BY PHARMACISTS AND

PHARMACIES. An issuer of a health benefit plan that provides

prescription drug benefits or a pharmacy benefit manager that

administers pharmacy benefits may not, by contract or otherwise,

prohibit or restrict a pharmacist or pharmacy from informing an

enrollee of any difference between the enrollee's out-of-pocket

cost for a prescription drug under the enrollee's health benefit

plan and the out-of-pocket cost without submitting a claim under

the enrollee's health benefit plan.

SECTION 2. If before implementing any provision of this Act

a state agency determines that a waiver or authorization from a

federal agency is necessary for implementation of that provision,

the agency affected by the provision shall request the waiver or

authorization and may delay implementing that provision until the

waiver or authorization is granted.

SECTION 3. This Act takes effect September 1, 2025.